Compare
ProtoKinetix, Inc. vs Bio Essence Corp vs Polomar Health Services, Inc. vs Bioxytran, Inc
| Latest fiscal year | ProtoKinetix, Inc. PKTX | Bio Essence Corp BIOE | Polomar Health Services, Inc. PMHS | Bioxytran, Inc BIXT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $1.90M | $648.2K | n/a |
| Revenue growth (YoY) | n/a | +485.8% | n/m | n/a |
| Gross margin | n/a | 75.3% | 71.0% | n/a |
| Operating margin | n/a | 47.4% | n/m | n/a |
| Net margin | n/a | 47.2% | n/m | n/a |
| Net income | -$393.6K | $896.2K | -$10.70M | -$2.12M |
| EPS (Diluted) | $0.00 | n/a | -$0.39 | -$0.02 |
| Operating cash flow | -$135.4K | $1.57M | -$396.0K | -$526.5K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | n/a | n/a | $132.2K | n/a |
| Total assets | $483.4K | $422.5K | $390.0K | $658.6K |
| Total liabilities | n/a | $2.50M | $1.61M | $3.25M |
| Shareholders' equity | $297.9K | -$2.07M | -$1.22M | -$2.59M |
| Return on year-end equity | -132.1% | n/a | n/a | n/a |
| Shares outstanding | 406.83M | 38.01M | 28.02M | 108.15M |
Revenue, most recent five fiscal years
| Fiscal year | ProtoKinetix, Inc. | Bio Essence Corp | Polomar Health Services, Inc. | Bioxytran, Inc |
|---|---|---|---|---|
| Latest | $0 Ended 2014-12-31 | $1.90M Ended 2025-12-31 | $648.2K Ended 2025-12-31 | $191.1K Ended 2017-12-31 |
| 1 year earlier | $0 Ended 2013-12-31 | $323.9K Ended 2024-12-31 | $58.8K Ended 2024-12-31 | $246.5K Ended 2016-12-31 |
| 2 years earlier | $0 Ended 2012-12-31 | $551.5K Ended 2023-12-31 | $41.8K Ended 2023-12-31 | $255.8K Ended 2015-12-31 |
| 3 years earlier | $0 Ended 2011-12-31 | $621.6K Ended 2022-12-31 | $34.5K Ended 2022-12-31 | $275.6K Ended 2014-12-31 |
| 4 years earlier | $0 Ended 2010-12-31 | $888.0K Ended 2021-12-31 | n/a | $417.3K Ended 2013-12-31 |